We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How a product complies with EU safety, health and environmental requirements, and how to place a CE marking on your product.
How to use a cost benefit analysis to evaluate your digital health product.
The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. NICE is an executive non-departmental public body, sponsored by the Department of Health and Social Care .
Planning practice guidance on biodiversity net gain. Biodiversity net gain is a way of creating and improving biodiversity by requiring development to have a positive impact (‘net gain’) on biodiversity.
How to use a before-and-after study to evaluate your digital health product.
Investors and businesses may be legally required to tell the government about certain sensitive acquisitions under the National Security and Investment Act.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to use a cost utility analysis to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Tax advantages on employee share schemes including Share Incentive Plans, Save As You Earn, Company Share Option Plans and Enterprise Management Incentives
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Find out what to do and how much it costs to record allocation of off-site biodiversity gains to a development.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How developers can use habitat creation or enhancements to count towards their biodiversity net gain (BNG).
Find out how to operate PAYE if you pay your employees with assets that can be sold or cashed in, like stocks, shares or cryptoassets.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Developers should fill in this form to show how a development will achieve biodiversity net gain (BNG).
How developers can create and enhance habitat off-site or buy biodiversity units to achieve biodiversity net gain (BNG).
Relief from Capital Gains Tax (CGT) when you sell your home - Private Residence Relief, time away from your home, what to do if you have 2 homes, nominating a home, Letting Relief
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).